While all B. pseudomallei strains grew on all three tested selective agars, the other Burkholderia spp. showed a diverse growth pattern. Nontarget organisms, i.e., nonfermentative rod-shaped bacteria, other species, and yeasts, grew on all selective agars. Colony morphology did not allow unambiguous discrimination.
Introduction
The genus Burkholderia harbors highly pathogenic species Burkholderia (B.) mallei, the causative agent of glanders, and Burkholderia pseudomallei, the causative agent of melioidosis [1, 2] , species with relevance for cystic fibrosis patients, e.g., the Burkholderia cepacia complex, and environmental species [3, 4] .
Considering the high clinical relevance of the correct identifi cation of glanders, melioidosis, or Burkholderiaassociated respiratory tract infections in cystic fi brosis patients, reliable identifi cation of the causative agent is important and incorrect identifi cation can lead to critical clinical courses [5] .
Melioidosis presents with unspecifi c symptoms and remains often unrecognized by the fi rst responder, i.e., the clinician at a private practice or a local hospital especially in nonendemic areas where the physicians are unaware of the disease [6] . Blood culture in case of sepsis and subsequent culture on standard routine media result in un-
This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 License, which permits unrestricted use, distribution, and reproduction in any medium for non-commercial purposes, provided the original author and source are credited. specifi c growth, comparable to that of many other Gramnegative nonglucose fermenting rod-shaped bacteria like Pseudomonas spp. Subsequent routine testing using commercially available tests, such as API20 (bioMérieux, Nür tingen, Germany), VITEK2 (bioMérieux), etc., has proven to be little specifi c. Routine matrix-assisted laser desorption-ionization time-of-fl ight mass spectrometry (MALDI-TOF-MS) systems lack profi les for this agent in their databases. The use of selective agars, i.e., MacConkey, Ashdown's, B. pseudomallei selective, and B. cepacia selective agar and prolonged incubation for specimens being contaminated with normal fl ora, is strongly advised to increase sensitivity. A very good review describing these problems and a suitable work fl ow in detail has recently been published [7] .
Specialized laboratories use a plethora of tests to fi nally identify the agent. Molecular diagnostics are hampered by the close relationship of B. pseudomallei to B. mallei and Burkholderia thailandensis, the cause of zoonotic glanders, and a fairly apathogenic soil bacterium, respectively [8] . Specifi c antibodies to detect B. pseudomallei are not commercially available, and thus, tests based on these tools have not been validated accordingly. Laboratory infection may occur, and it is strongly advised to work only under BSL-3 biosafety laboratory conditions if melioidosis or B. pseudomallei/mallei is suspected.
For the reliable discrimination of other Burkholderia spp., e.g., strains of the B. cepacia complex, sequencebased molecular tools have been introduced. They comprise multilocus sequence typing (MLST) [9] , fur sequencing [10] , hisA sequencing [11] , or recA sequencing [12, 13] from pure cultures. MALDI-TOF-MS-based approaches have been described as well [14] [15] [16] [17] . All of these procedures, however, require the identifi cation of suspicious colonies by the investigator.
Although clinically relevant Burkholderia spp. readily grow on standard agars like blood agar [3, 4] , there is the risk that they may be missed if only few colonies are present among colonies of a majority of apathogenic fl ora from primarily nonsterile sampling sites.
Selective agars are used to facilitate selective growth and, thus, to ease identifi cation of pathogens [18, 19] . Such selective agars are usually based on chemicals or antibiotic drugs with inhibitory effects on nontarget organisms, often associated with chromogenic reactions, which further facilitate the identifi cation of the target pathogen [20] [21] [22] . Hence, evaluations of the discriminatory potential of the selective agar are imminent.
Here we assessed the reliability of three selective agars for Burkholderia spp. using a strain collection comprising a considerable number of target and nontarget organisms. Parallel growth on blood agar was done as a growth control in parallel. The aim was the analysis of both the sensitivity and selectivity of the assessed selective agars to provide a recommendation for the routine diagnostics based on the results.
Materials and methods

Strains
A strain collection of 116 reference strains and clinical isolates was used for the assessment. Only strains that grew either on blood agar or at least on one of the selective agars were included in the assessment. The used strains comprised 30 B. pseudomallei strains, 20 B. mallei strains, 18 strains from other Burkholderia spp., and 48 nontarget strains. The distribution of species and strains is detailed in Table 1 . Burkholderia cepacia (n = 3) Isolate-6-19-175, ATCC 25416, isolate (n = 1)
Burkholderia anthina (n = 1) LMG 20982
Burkholderia stabilis (n = 2) LMG 14294, isolate (n = 1)
Burkholderia thailandensis (n = 2) DSM 13276, ATCC700388
Burkholderia vandii (n = 2) DSM 9509, DSM 951/LMG 16020
Burkholderia vietnamensis (n = 1) DSM 11319
Burkholderia cenocepacia (n = 1) LMG 12615
Burkholderia cocovenenans (n = 1) DSM 4285 
Species Strains
Burkholderia dolosa (n = 1) LMG 18941
Burkholderia fungorum (n = 1) LMG 16225
Burkholderia gladioli (n = 1) DSM 11318
Burkholderia glumae (n = 1) DSM 9512/LMG 2196
Burkholderia graminis (n = 1) LMG 18924
Nontarget strains
Francisella tularensis (n = 4) Isolates (n = 4)
Pseudomonas aeruginosa (n = 2) DSM 11810, ATCC 27853
Achromobacter ruhlandii (n = 1) DSM 653
Achromobacter xylosoxidans spp. dentrificans (n = 1) DSM 30026
Acinetobacter baumannii (n = 1) DSM 4372
Aeromonas hydrophila spp. hydrophila (n = 1) ATCC 7966
Alcaligenes faecalis spp. faecalis (n = 1) DSM 30030
Bacillus cereus (n = 1) DSM 4222
Bacillus kururiensis (n = 1) DSM 13646
Bacillus mycoides (n = 1) DSM 2048
Bacillus polymyxa (n = 1) ATCC 10401
Bacillus stearothermophilus var. calidolactis (n = 1) DSM 5943
Bacillus thuringiensis (n = 1) DSM 350/WIS 315
Candida albicans (n = 1) DSM1386
Chromobacterium violaceum (n = 1) LMG 1267
Eikenella corrodens (n = 1) DSM 8340
Enterobacter aerogenes (n = 1) DSM 12058
Enterobacter cloacae (n = 1) ATCC 13047
Enerococcus faecalis (n = 1) DSM 2570
Escherichia coli (n = 1) DSM 301
Kingella dentrificans (n = 1) DSM 10202
Klebsiella oxitoca (n = 1) Isolate Klebsiella pneumoniae spp. pneumoniae (n = 1) DSM 6675/681
Listeria monocytogenes (n = 1) DSM 12464
Moraxella catarrhalis (n = 1) DSM 9143
Morganella morganii (n = 1) DSM 6675
Ochrobactrum anthropi (n = 1) DSM 7216
Proteus mirabilis (n = 1) DSM 4479
Proteus vulgaris (n = 1) DSM 30118
Psychrobacter phenylpyruvicus (n = 1) DSM 7000
Salmonella Typhimurium (n = 1) ATCC 13311
Shigella flexneri (n = 1) DSM 4782
Sphingomonas paucimobilis (n = 1) DSM 1098
Staphylococcos aureus (n = 1) DSM 346
Staphylococcus epidermidis (n = 1) DSM 1798
Stenotrophomonas maltophila (n = 1) DSMZ 50170
Streptococcus agalactiae (n = 1) Isolate
Streptococcus pyogenes (n = 1) Isolate
Vibrio cholerae (n = 1) 219512
Inoculation on agars and growth assessment were performed by skilled laboratory technical assistants.
Agars
Blood agar was used as a nonselective medium to control the vitality of strains. Further assessment on selective agars was only performed if growth on blood agar was observed. Blood agar was made of pancreatically digested casein, 12.0 g/L; peptically digested animal tissue, 5.0 g/L; yeast extract, 3.0 g/L; beef extract, 3.0 g/L; starch from corn, 1.0 g/L; sodium chloride, 5.0 g/L; agar-agar, 13.5 g/L; and defi brinized sheep blood, 5% with reagents provided by Merck (Darmstadt, Germany). Plates of each charge were incubated for sterility assessment.
The Mast BCA (B. cepacia agar) was prepared according to the manufacturer's instructions using B. cepacia medium, 36 g/L (Mast Diagnostica Ltd., Reinfeld, Germany); bidistilled water; and B. cepacia supplement, 10 tablets per liter (Mast Diagnostica Ltd). Ashdown + G (G for gentamicin) agar was made of tryptone soy broth agar, 10 g/L; agar-agar, 15 g/L; crystal violet, 5 mg/L; neutral red, 50 mg/L; 40% glycerol stock solution, 100 mL/L; gentamicin, 5 g/L; and bidistilled water with reagents provided by Merck. B. pseudomallei selective agar (BPSA, Nile blue agar) was prepared using standard agar, 23.5 g/L (Becton & Dickinson, Heidelberg, Germany); maltose, 4 g/L (Merck); neutral red, 100 mg/L (Merck); gentamicin, 20 mg/L (Merck); Nile blue, 0.2 g/L (Sigma, Munich, Germany); and bidistilled water as described [20, 21] .
Growth assessment
Cultural growth and growth characteristics on selective agar plates were assessed 24 hours (h), 48 h, and 7 days (d) after inoculation of the media. Investigated growth characteristics were observation of grown normal-sized or at least very tiny colonies (later referred to as weak growth), assessment of color, transparency, size, shape, profi le and surface qualities of grown colonies, and occurring of color shifts on selective agar if applicable.
Ethics
Ethical clearance was not necessary for this study because only bacterial strains from a strain collection were assessed. (Table 2) .
Results
Cultural growth of
Growth was visible after 2 days for most strains (Supplementary materials 1-3, Table 2 ). In detail, fi rst detection of growth after more than 48 h was recorded for 4 B. mallei strains and 1 B. cocovenenans strain on Mast BCA as well as for 1 B. stabilis strain on both Ashdown + G agar and BPSA (Nile blue). A more differentiated discrimination of "clearly visible" and "very weak" growth of colonies is shown in Table 2 .
Cultural growth of nontarget organisms on selective agars
Each selective agar showed cultural growth of nontarget organisms, mainly of nonfermentative Gram-negative rod-shaped bacteria, but also other species like Enterobacteriaceae, yeasts, and Gram-positive bacteria were observed. Often, only weak growth was detectable ( Table 
Species Strains
Vibrio parahaemolyticus (n = 1) DSM 10027
Yersinia enterocolitica (n = 1) DSM 4780
Yersinia kristenseni (n = 1) ATCC 33638
Yersinia pestis (n = 1) EV 76
Yersinia pseudotuberculosis (n = 1) ATCC 29833 Burkholderia anthina (n = 1)
Burkholderia vietnamensis (n = 1)
Burkholderia cenocepacia (n = 1)
Burkholderia cocovenenans (n = 1)
Burkholderia dolosa (n = 1)
Burkholderia fungorum (n = 1)
Burkholderia gladioli (n = 1)
Burkholderia glumae (n = 1)
Burkholderia graminis (n = 1)
Growth of nontarget organisms Achromobacter ruhlandii (n = 1)
Achromobacter xylosoxidans spp.
denitrifi cans
Acinetobacter baumannii (n = 1)
Aeromonas hydrophila spp. hydrophila
Alcaligenes faecalis spp. faecalis 
Weak growth only
Bacillus cereus (n = 1)
Bacillus kururiensis (n = 1)
Bacillus mycoides (n = 1)
Bacillus polymyxa (n = 1)
Bacillus thuringiensis (n = 1)
Candida albicans (n = 1)
Chromobacterium violaceum (n = 1)
Eikenella corrodens (n = 1)
Enterobacter aerogenes (n = 1)
Enterobacter cloacae (n = 1)
Enterococcos faecalis (n = 1)
Escherichia coli (n = 1)
Kingella denitrifi cans (n = 1)
Klebsiella oxytoca (n = 1)
Klebsiella pneumoniae spp. pneumo-
Listeria monocytogenes (n = 1)
Moraxella catarrhalis (n = 1)
Morganella morganii (n = 1)
Ochrobactrum anthropi (n = 1)
Proteus mirabilis (n = 1)
Proteus vulgaris (n = 1)
Psychrobacter phenylpyruvicus (n = 1)
Salmonella Typhimurium (n = 1) Table 2 ). In detail, growth of only a few nontarget strains was detected after more than 48 h, comprising 1 F. tularensis strain on both Mast BCA and BPSA (Nile blue), 1 C. albicans strain on Mast BCA, and 1 A. hydrophila spp. hydrophila strain as well as 1 E. faecalis strain on Ashdown + G agar.
Morphological features of Burkholderia spp. and nontarget organisms on the selective agars
The morphological features of colonies of Burkhol deria spp. and nontarget organisms are shown in Tables  3-5 . Colony morphology was strain-dependent. Typical "species-specifi c" colonies were not observed. Colonies were likely to change their morphological features during growth. Nontarget organisms showed highly similar colony morphology (Tables 3-5) to Burkholderia spp., making the risk of misdiagnosis highly likely. Considerable intraspecies variety and morphological changes during growth were observed for the nontarget species.
Discussion
The study assessed the reliability of three different selective media, i.e., Mast BCA, Ashdown + G agar, and BPSA (Nile blue), for selectivity for Burkholderia spp. The results showed that all three agars are suitable to allow the growth of B. pseudomallei. This result confi rms the fi ndings of Roesnita et al. [23] that B. pseudomallei selective agar (BPSA) is a cost-effi cient screening tool for melioidosis in a low prevalence setting. The authors identifi ed one additional case of melioidosis and three additional culture-positive samples for B. pseudomallei by applying this agar in comparison to standard diagnostic procedures with nonselective media [23] . BPSA was fi rst introduced in 2003 [20] for the selective cultivation of B. pseudo mallei. According to the results of the authors, BPSA shall be inhibitory to nonfermentative nontarget organisms like P. aeruginosa as well as Burkholderia spp. of the B. cepacia complex [20] or other nonpathogenic species. The here presented data cannot confi rm their results 
Weak growth only
Sphingomonas paucimobilis (n = 1)
Staphylococcos aureus (n = 1)
Staphylococcus epidermidis (n = 1)
Stenotrophomonas maltophila (n = 1)
Streptococcus agalactiae (n = 1)
Streptococcus pyogenes (n = 1)
Vibrio cholerae (n = 1)
Vibrio parahaemolyticus (n = 1)
Yersinia enterocolitica (n = 1)
Yersinia kristenseni (n = 1)
Yersinia pestis (n = 1)
Yersinia pseudotuberculosis (n = 1) as P. aeruginosa and B. cepacia strains grew on this agar. In another comparison of BCA, Ashdown agar, and BPSA using clinical samples, the sensitivity of all three agars for the isolation of B. pseudomallei was virtually equivalent [24] . Ashdown agar and BCA were more specifi c with clinical samples [24] , a result which cannot be confi rmed by the here presented data with reference strains and wellcharacterized clinical isolates. In this study, only some strains of Burkholderia spp. other than B. pseudomallei grew on the selective media. This was observed not only for environmental Burkholderia spp., which are lacking practical relevance for diagnostic procedures in human medicine, but also for strains with high relevance like B. mallei, the causative agent of glanders. The results indicate that the media are nonreliable for the growth of Burkholderia spp. other than B. pseudomallei considerably decreasing their diagnostic use.
Focusing on combined approaches for the detection of B. pseudomallei and B. mallei, the causative agents of melioidosis and glanders, respectively [1, 2], Ashdown agar was described to be most sensitive for the isolation of B. pseudomallei [25] . The fi nding of that study [25] that growth of B. mallei generally fails on this medium, however, could not be confi rmed by the here presented data using Ashdown + G agar, although the agar did not allow the growth of all B. mallei strains investigated. Interestingly, however, 4 B. mallei strains were detected after more than 48 h after onset of growth on Ashdown + G agar in the here presented study. A similar effect was observed for other Burkholderia spp. on other assessed selective agars. An incubation time longer than the usually applied 48 h in the diagnostic routine is therefore advisable to increase the sensitivity of the assessed selective agars. The here presented data show that the proportion of nontarget organisms that became visible later than 48 h after the onset of growth is low. This limits the importance of the disadvantage of the also supported nonspecifi c growth due to the prolonged incubation time. Glass et al. preferred the use of Pseudomonas cepacia agar (PCA), which proved to be both sensitive and selective in their assessment [25] , if the growth of both B. mallei and B. pseudomallei is desired.
Focusing on clinically relevant species of the B. cepacia complex and on environmental Burkholderia species, the metabolic needs differ in a species-depending way. Of note, L-arabinose was the most frequently used carbon source utilized by species of the B. cepacia complex, supporting the growth of 90% of the isolates in a previous study [26] , while B. anthina and B. vietnamensis were most susceptible to antibiotic drugs. The latter results are confi rmed by the present study, as no growth of B. anthina and B. vietnamensis strains on Ashdown + G agar and BPSA was seen. Previous analyses [4] , however, suggested that antibiotic resistance seems to be more straindependent than species-dependent, especially in isolates from cystic fi brosis patients under antibiotic pressure. tive agar (BCSA) [26] , refl ecting the different needs of the various Burkholderia spp. by means of the composition of growth media. In this study, the observed intraspecies variance of growth characteristics on the selective media does not allow any discrimination at species level, which is similar to the observations by Vermis et al. [26] . Another study that compared BCA with BCSA for the identifi cation of B. cepacia complex strains from sputum samples of cystic fi brosis patients suggested that BCSA has a higher selectivity and reduced time to detection [27] . BCSA was fi rst described in 1997 [22] as a selective medium for the identifi cation of B. cepacia complex strains from respiratory secretions of cystic fi brosis patients. The intention was to use it as an agar for primary isolation, and it proved to be superior in comparison with the older oxidation-fermentation polymyxin-bacitracinlactose ( OFPBL) agar [28] and P. cepacia agars (PCA), that also readily allowed growth of other nonfermentative Gram-negative rod-shaped bacteria like Stenotrophomonas maltophilia, Alcaligenes xylosoxidans, and Comamonas acidovorans. Growth of B. cepacia strains on BCSA was also faster [22] than on OFPBL agar and PCA. In a later report, those fi ndings were confi rmed for sputum samples from cystic fi brosis patients as well [29] .
It remains controversial whether or not prior broth enrichment may help to increase the sensitivity of selective agars for Burkholderia spp. An old report showed slightly better performance for selective enrichment and culture on polymyxin B-MacConkey agar without crystal violet, PCA, and OFPBL agar [30] . A later study could not confi rm those fi ndings and showed identical results for direct primary use of BCSA and for enrichment broth subcultures prior to growth on the selective agar [31] . The question whether or not prior enrichment is necessary to reliably identify Burkholderia spp. from respiratory samples of patients with cystic fi brosis is not fi nally answered so far.
The three media tested did not reliably suppress the growth of nonpathogenic Burkholderia spp. and not even of nontarget organisms like facultatively pathogenic Pseudomonas and Enterobacteriaceae which are frequently isolated from primarily sterile body compartments in case of invasive infections, thus, potentially mimicking invasive Burkholderia infections. The fact that even the growth of fungi was supported by the selective media, is in line with the recent fi nding that BCSA can be used for the isolation of Exophiala dermatitidis, a typical causative agent of phaeohyphomycosis [32] .
Conclusion
The selective media investigated are of only restricted usefulness for diagnostic purposes with regard to both sensitivity and specifi city. Their usefulness for the identifi cation of B. pseudomallei [20, 23, 24] was confi rmed again. In contrast, the identifi cation of other Burkholderia spp. turned out to be nonreliable. Therefore, screening in case of suspicion of infections due to Burkholderia spp. should not exclusively be based on the three selective agars tested here but should also include use of nonselective media and subsequent differentiation [33] [34] [35] . 
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